Astellas Pharma EBITDA 2012-2024 | ALPMY

Astellas Pharma EBITDA for the quarter ending December 31, 2024 was $0.646B, a 19.8% increase year-over-year.

  • Astellas Pharma 2024 EBITDA was 1.215B, a 0% decline from 2024.
  • Astellas Pharma 2024 EBITDA was 1.215B, a 32.31% decline from 2023.
  • Astellas Pharma 2023 EBITDA was 1.795B, a 0% decline from 2023.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Astellas Pharma EBITDA 2012-2024 | ALPMY

  • Astellas Pharma 2024 EBITDA was 1.215B, a 0% decline from 2024.
  • Astellas Pharma 2024 EBITDA was 1.215B, a 32.31% decline from 2023.
  • Astellas Pharma 2023 EBITDA was 1.795B, a 0% decline from 2023.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.